FDA To Manufacturers: Describe Adverse Events More Fully
This article was originally published in The Silver Sheet
Executive Summary
FDA URGES FIRMS TO COMPLETE ADVERSE EVENT REPORT NARRATIVES so the agency will better understand the nature of the incident. Meanwhile, a new chart designed by CDRH's Office of Surveillance & Biometrics describes what FDA does with the reports it receives